Catalyst Pharmaceuticals (CPRX) Leases (2019 - 2026)

Catalyst Pharmaceuticals (CPRX) has 8 years of Leases data on file, last reported at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Leases fell 13.9% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (down 13.9% YoY), and the FY2025 full-year result was $1.9 million, down 13.23% from the prior year.
• Leases for Q1 2026 stood at $1.9 million, down from $1.9 million in the prior quarter.
• Across five years, Leases topped out at $3.0 million in Q1 2022 and bottomed at $1.9 million in Q1 2026.
• The 5-year median for Leases is $2.4 million (2024), against an average of $2.4 million.
• The widest annual swing landed in 2022, when Leases fell 8.19%; it then slipped 13.9% in 2026.
• A 5-year view of Leases shows it stood at $2.8 million in 2022, then fell by 9.46% to $2.5 million in 2023, then slipped by 11.08% to $2.2 million in 2024, then fell by 13.23% to $1.9 million in 2025, then dropped by 3.98% to $1.9 million in 2026.
• The last three Leases figures came in at $1.9 million (Q1 2026), $1.9 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.

Peer Comparison